Aspargo Laboratories, Inc. is a clinical-stage biopharmaceutical company developing patient-focused solutions and must-have medicines by combining their innovative science and technologies and FDA’s 505(b)(2) approval pathway to enhance currently marketed drugs with well-known pharmacology profiles.